Mood Clinical Trial
Official title:
A Randomized, Double-blinded, Placebo-controlled, Crossover Study, to Assess the Synergistic Effects of a Cranberry Beverage on Cognitive Function
Verified date | July 2023 |
Source | Ocean Spray Cranberries, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to determine the effect short-term dosing (7 days) of a placebo beverage, cranberry juice, cranberry juice + lemon balm extract, cranberry juice + tart cherry powder, or cranberry juice + L-theanine or L-theanine beverage on cognitive function and mood in healthy adults (18-45 years). The study will include measures of attention, alertness, performance, and mood/stress.
Status | Completed |
Enrollment | 25 |
Est. completion date | November 1, 2021 |
Est. primary completion date | November 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: To be eligible for inclusion, the participant must fulfil all of the following criteria: 1. Be able to give written informed consent and willing/able to comply with study procedures. 2. Be between 18 and 45 years, inclusive. 3. Is in general good health, as determined by the investigator. 4. Has a BMI between =20 - =35 kg/m2. 5. Has had a stable body weight (=5 % change) over the past 3-months. 6. Has a Beck Depression Inventory II score =20 at screening. 7. Willing to discontinue consumption of wine and dark red/blue colored fruits and polyphenol-rich fruits (e.g., pomegranate, blueberries, grapes), lemon balm, tart cherry powder, and L-Theanine for the two weeks leading up to the study (from the Screening visit V1 to baseline V2) and during the study. 8. Willing and able to avoid consumption of any cranberry juice, whole cranberries, and dried cranberries for the two weeks leading up to the study (from the Screening visit V1 to baseline V2) and during the study, excluding the study beverage. 9. Is willing to provide saliva samples. 10. Maintain current level of physical activity and dietary habits throughout the study. Exclusion Criteria: Participants that meet any of the following criteria will be excluded from the trial: 1. Has a known or suspected allergy to components of the investigational product (e.g., cranberries, tart cherry, lemon balm, L-theanine). 2. Uncontrolled blood pressure or untreated hypertension. 3. Consumes >2 alcoholic beverages per day or >14 per week. 4. Major chronic illness or health condition that might interfere with the study outcomes at the discretion of the study clinician or principal investigator. 5. Use of antidepressant, anxiolytic, Central Nervous System stimulant, antipsychotic, antimanic, anti-inflammatory (except for aspirin and non-steroidal anti-inflammatory drugs [NSAIDS]. Multivitamins, vaccines, gender affirming hormones, HIV prevention medications, allergy medications, topical steroids are allowed for inclusion.) 6. Individuals who smoke or use nicotine patches or gum or e-cigarettes, or marijuana (within the past 6 months). 7. Individuals who have experienced a stroke or a head injury with concussion, loss of consciousness or seizures. 8. History or clinical manifestation of any significant neurologic disorder in the opinion of the investigator and/or study clinician. 9. Any disease, that by the investigator's judgement, could interfere with the intestinal barrier function, including Celiac disease (Lactose intolerance or acid reflux are allowed for inclusion). 10. Participants may not be receiving treatment involving experimental drugs. If the participant has been in a recent experimental trial, these must have been completed not less than one month prior to this trial. 11. Desire and/or plans on changing current diet and/or exercise regime during the participation of this trial. 12. Individuals who are pregnant or lactating. 13. Individuals currently of childbearing potential, but not using an effective method of contraception, as determined by the investigator. 14. History of heavy caffeinated beverage consumption (>400 mg caffeine/day - or 4 cups of coffee per day) within past 2 weeks prior to the Screening Visit (V1), or before their Baseline Visit (V2). |
Country | Name | City | State |
---|---|---|---|
United States | Atlantia Clinical Trials Ltd | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Ocean Spray Cranberries, Inc. | Atlantia Food Clinical Trials |
United States,
Chai SC, Jerusik J, Davis K, Wright RS, Zhang Z. Effect of Montmorency tart cherry juice on cognitive performance in older adults: a randomized controlled trial. Food Funct. 2019 Jul 17;10(7):4423-4431. doi: 10.1039/c9fo00913b. — View Citation
Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med. 2004 Jul-Aug;66(4):607-13. doi: 10.1097/01.psy.0000132877.72833.71. — View Citation
Kennedy DO, Scholey AB, Tildesley NT, Perry EK, Wesnes KA. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002 Jul;72(4):953-64. doi: 10.1016/s0091-3057(02)00777-3. — View Citation
Lamport DJ, Williams CM. Polyphenols and Cognition In Humans: An Overview of Current Evidence from Recent Systematic Reviews and Meta-Analyses. Brain Plast. 2021 Feb 9;6(2):139-153. doi: 10.3233/BPL-200111. — View Citation
Scholey A, Gibbs A, Neale C, Perry N, Ossoukhova A, Bilog V, Kras M, Scholz C, Sass M, Buchwald-Werner S. Anti-stress effects of lemon balm-containing foods. Nutrients. 2014 Oct 30;6(11):4805-21. doi: 10.3390/nu6114805. — View Citation
Travica N, D'Cunha NM, Naumovski N, Kent K, Mellor DD, Firth J, Georgousopoulou EN, Dean OM, Loughman A, Jacka F, Marx W. The effect of blueberry interventions on cognitive performance and mood: A systematic review of randomized controlled trials. Brain B — View Citation
Williams JL, Everett JM, D'Cunha NM, Sergi D, Georgousopoulou EN, Keegan RJ, McKune AJ, Mellor DD, Anstice N, Naumovski N. The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review. — View Citation
Yokogoshi H, Kobayashi M, Mochizuki M, Terashima T. Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 1998 May;23(5):667-73. doi: 10.1023/a:1022490806093. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Proportion of Adverse Events). | Proportion of Adverse Events per treatment phase by product causality. | 7 days | |
Other | To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Incidence of Adverse Events). | Incidence of mild, moderate, and severe Adverse Events per treatment phase by product causality. | 7 days | |
Other | To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Incidence of Serious Adverse Events). | Incidence of Serious Adverse Events per treatment phase by product causality. | 7 days | |
Other | To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Blood Pressure). | Change in Blood Pressure from Baseline to each subsequent visit (V3-8). | 7 days | |
Other | To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Heart Rate). | Change in Heart Rate from Baseline to each subsequent visit (V3-8). | 7 days | |
Other | To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Body Temperature). | Change in Body Temperature from Baseline to each subsequent visit (V3-8). | 7 days | |
Primary | To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on attention. | Change in Accuracy of Attention and Change in Speed of Attention composite scores outcomes from Baseline to each treatment phase (V3-8), assessed using the COMPASS cognitive assessment tool. | 7 days | |
Secondary | To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of focus. | Change in Overall % accuracy scores outcomes from Baseline to each treatment phase (V3-8), assessed using the STROOP task in the COMPASS cognitive assessment tool. | 7 days | |
Secondary | To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of alertness. | Change in Alertness scores outcomes from Baseline to each treatment phase (V3-8), assessed using the self-rated Alertness Visual Analogue Scale in the COMPASS cognitive assessment tool. | 7 days | |
Secondary | To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of cognition (accuracy of performance). | Change in Accuracy of Performance composite scores outcomes from Baseline to each treatment phase (V3-8), assessed using the COMPASS cognitive assessment tool. | 7 days | |
Secondary | To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of cognition (speed of performance). | Change in Speed of Performance composite scores outcomes from Baseline to each treatment phase (V3-8), assessed using the COMPASS cognitive assessment tool. | 7 days | |
Secondary | To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on mood. | Change in Total Mood Disturbance scores from Baseline to each subsequent visit (V3-8), assessed using the Profile of Mood States-Short Questionnaire. | 7 days | |
Secondary | To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on stress. | Change in salivary cortisol from Baseline to each treatment phase (V3-8). | 7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05516264 -
Behavioural and Physiological Responses to Dog Visits in Nursing Homes
|
N/A | |
Completed |
NCT05555186 -
The Effects of Bright Light Therapy on Adolescent's Sleep Quality and Well-being
|
N/A | |
Completed |
NCT04706806 -
Effect of Daily Vinegar Ingestion for Four Weeks on Mood State in Healthy College Students
|
N/A | |
Completed |
NCT04013451 -
The Kiss of Kindness Study II
|
N/A | |
Completed |
NCT03689348 -
Acute and Chronic Effects of Avena Sativa on Cognition and Stress
|
N/A | |
Completed |
NCT04440553 -
A Mobile App to Increase Physical Activity in Students
|
N/A | |
Completed |
NCT04505800 -
Tryptophan Supplementation to Improve Night Shift Workers' Health
|
N/A | |
Active, not recruiting |
NCT06082778 -
ZOE's Ferment Experiment
|
N/A | |
Completed |
NCT05100589 -
Effect of PeakATP on Mood, Reaction Time and Cognition
|
N/A | |
Completed |
NCT05559372 -
Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes
|
N/A | |
Active, not recruiting |
NCT04641689 -
Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment
|
N/A | |
Active, not recruiting |
NCT01725425 -
The Effect of Portion Sizes on Mood
|
N/A | |
Completed |
NCT01794351 -
Cognitive Effects of 500mg Trans-resveratrol
|
N/A | |
Completed |
NCT05550610 -
Evaluation of Mindfulness and Yoga in Basic Combat Training
|
N/A | |
Recruiting |
NCT05939453 -
Impact of Bright Light Therapy on Prader-Willi Syndrome
|
N/A | |
Recruiting |
NCT05058872 -
Contraceptive Hormone and Reward Measurement (CHARM Study)
|
Phase 4 | |
Not yet recruiting |
NCT04551274 -
Music Therapy in Frontline Healthcare Workers
|
N/A | |
Completed |
NCT03105973 -
Technology Enabled Mental Health Intervention for Individuals in the Criminal Justice System
|
N/A | |
Completed |
NCT04075448 -
The Acute Effect of a Walnut Intervention on Cognitive Performance, Brain Activation, and Serum Markers of Inflammation in Young Adults
|
N/A |